Brittany L. Feijoo is a Research Associate and Nurse Practitioner in the Department of International Health at the Johns Hopkins University Bloomberg School of Public Health. She joined the Center for Immunization Research (CIR) in 2015. At the CIR, she is a Co-Investigator on Phase 1 and Phase 2 vaccine trials and challenge studies involving Enterotoxigenic E. coli (ETEC), Shigella, Respiratory Syncytial Virus (RSV), and Ebola. She is currently involved in Phase 3 COVID-19 vaccine trials at the CIR. Ms. Feijoo is also a Co-Instructor for the “Good Clinical Practice: A Vaccine Trials Perspective” course at the Bloomberg School of Public Health.
Prior to working at the Bloomberg School of Public Health, she worked as a Clinical Research Nurse at the National Institutes of Health (NIH), Clinical Center. At NIH, she worked with an interdisciplinary team on natural history study protocols with conditions such as human immunodeficiency virus (HIV), sickle cell anemia, and chronic granulomatous disease.